Henderson Group »

Revance Therapeutics shares owned by Henderson Group

Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Henderson Group from 13F filings

Historical chart of Henderson Group investment in Revance Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Revance Therapeutics held by Henderson Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revance Therapeutics by Henderson Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $339k 39k 8.80
2023-09-30 $443k 39k 11.47
2023-06-30 $976k 39k 25.30
2023-03-31 $1.2M 39k 32.19
2022-12-31 $255k 14k 18.46
2022-09-30 $630k 24k 26.49
2022-03-31 $280k 14k 20.32
2021-12-31 $225k 14k 16.32